Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review
2023
Zurabi Lominadze | Kareen Hill | Mohammed Rifat Shaik | Justin P. Canakis | Mohammad Bourmaf | Cyrus Adams-Mardi | Ameer Abutaleb | Lopa Mishra | Kirti Shetty
The emerging field of immuno-oncology has brought exciting developments in the treatment of hepatocellular carcinoma (HCC). It has also raised urgent questions about the role of immunotherapy in the setting of liver transplantation, both before and after transplant. A growing body of evidence points to the safety and efficacy of immunotherapeutic agents as potential adjuncts for successful down-staging of advanced HCCs to allow successful transplant in carefully selected patients. For patients with recurrent HCC post-transplant, immunotherapy has a limited, yet growing role. In this review, we describe optimal regimens in the setting of liver transplantation.
Mostrar más [+] Menos [-]Palabras clave de AGROVOC
Información bibliográfica
Este registro bibliográfico ha sido proporcionado por Directory of Open Access Journals
